Navigation Links
Posit Science(R) Corporation Announces the Release of InSight(TM) 1.1
Date:11/13/2008

Brain fitness program that improves driving now includes personalized

progress tracking

SAN FRANCISCO, Nov. 13 /PRNewswire/ -- Effective immediately, Posit Science Corporation will begin shipping InSight Version 1.1 for Windows. This new release includes enhancements that enable users to closely track and understand the brain fitness gains they are making as they progress through the software, providing a highly personalized user experience.

InSight is a brain fitness software program that improves visual processing and memory. People's ability to take in and respond to what they see depends as much on the brain as the eyes. InSight speeds up and sharpens the brain's visual system so that people see more and react faster to what's around them, such as a child wandering into the street. Using InSight positively impacts essential daily activities, especially driving. In fact, InSight has been proven to cut the risk of auto accidents in half by dramatically improving driving performance.

InSight 1.1 allows users to track every step of their training experience through customized progress update messages. It also informs users about how the cognitive improvements they are making in the exercises will be expressed in everyday activities, such as grocery shopping, playing sports and driving.

Sixty-three year old Linda Stack is certain using InSight makes her a safer driver. "Lately, my peripheral vision was not what it should be," she said. "It was noticeable, especially when I was driving. I didn't want my wake up call to come when I had an accident so I was excited to try InSight. It has given me confidence and makes me feel that I can drive safely."

This new version of InSight also gives program participants flexibility to use InSight on more than one computer. Users can download their exercise data to pick up their training where they left off.

"We heard across the board from customers who
'/>"/>

SOURCE Posit Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
4. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
5. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
8. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
9. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
10. Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
11. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... MD (PRWEB) November 24, 2014 ... underrepresented patient populations into clinical trials at its ... , “Continental was created with the idea ... play a fundamental role in medical advances," said ... Tuskegee syphilis experiment to the immortal cell line ...
(Date:11/24/2014)... 2014 Senior Vice President, General ... leadership skills, business acumen Elsevier , ... products and services, congratulates Diane Bartoli , Senior ... Workflow, Elsevier Clinical Solutions, for being recognized in the ... Awards issue of Profiles in Diversity Journal ...
(Date:11/22/2014)... Prominent academics, leaders of the biopharmaceutical ... 3rd at Genetic Rx, a networking conference of ... place at the Joseph B. Martin Conference Center ... present and future of genetic medicines—including siRNA, ASOs, ... well as the treatment of patients with rare ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 The ... Analytical, Preparative), by Material (Metal, Glass, Plastic), by ... TLC, SFC] - Forecast to 2018” analyses and ... challenges in North America, Europe, Asia, and Rest ... tables and 15 figures spread through 135 pages ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... announced today that it has developed a new SARS specific ... now in the hands of USAMRIID (US Army Medical Research ... Central Public Health Laboratory (UK) and the British Columbia Center ... SARS genome, EraGen went to work immediately to develop a ...
... first-ever Wisconsin Entrepreneurs Conference in Milwaukee last week, it felt ... they were doing and what they planned to do. , ... plan to rid Lake Erie of the dreaded zebra mussel, ... making it the scourge of the entire Great Lakes region. ...
... - The instant Anca Copaescu, then a second-year MBA in ... 2001 G. Steven Burrill Technology Business Plan Competition, she knew ... winning $10,000 - though the money definitely got her attention. ... to fulfill one of her deepest dreams. "Even as a ...
Cached Biology Technology:EraGen Biosciences Ships SARS Diagnostic Test in Record Time 2Entrepreneurial Spirit Infectious in Milwaukee 2Entrepreneurial Spirit Infectious in Milwaukee 3Romanian Student Leverages Burrill Competition to Accomplish Her Dream 2Romanian Student Leverages Burrill Competition to Accomplish Her Dream 3
(Date:11/4/2014)... published research study examining only marketing directed at ... food restaurants has found that the majority of ... to such marketing tactics. , Authored by Arizona ... the study is the first to examine the ... exterior of fast food restaurants and its relationship ...
(Date:11/4/2014)... Lithuania , Nov. 4, 2014   ... technologies, today announced that the latest version of ... in the Ongoing MINEX evaluation organized ... of fingerprint algorithms using the INCITS 378 fingerprint ... mandatory requirement in public tenders in ...
(Date:11/3/2014)... LOS ANGELES , Nov. 3, 2014 /PRNewswire/ ... California -based life sciences company focused on ... eTNS system for the treatment of neurological ... Institute of Industrial Property has issued a Notice ... The patent application is co-owned by NeuroSigma and ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... pharmaceutical breakthroughs require 21st-century drug discovery tools, such ... high-throughput screening of effective, new compounds. That,s the ... be held Sept. 11 on "Twenty-first Century Bioscience: ... feature a variety of cutting-edge advances in the ...
... researchers today unveiled a prototype model of the first ... could eliminate the need for dialysis. The device, ... as a bioreactor to mimic the metabolic and water-balancing ... a collaborative effort by engineers, biologists and physicians nationwide, ...
... of Neuropsychopharmacology (ECNP) is pleased to announce Moussa B. ... Lifetime Achievement Award in recognition of his innovative and ... neuropsychiatric drug development. The ECNP Lifetime Achievement Award is ... the field of neuropsychopharmacology. The award is accompanied by ...
Cached Biology News:University at Buffalo symposium on in silico methods, high throughput screening 2University at Buffalo symposium on in silico methods, high throughput screening 3UCSF unveils model for implantable artificial kidney to replace dialysis 2UCSF unveils model for implantable artificial kidney to replace dialysis 3Moussa B.H. Youdim wins the 2010 ECNP Lifetime Achievement Award 2
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
TRBP1 Antibody...
Request Info...
Tracker Datamatrix TRxD reads any 1D and 2D barcodes within 0.5 seconds....
Biology Products: